Yahoo
Toronto - Delayed Quote CAD

Medexus Pharmaceuticals Inc. (MDP.TO)

5.12 +0.20 (+4.07%)
At close: November 6 at 4:00:00 PM EST
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
3/31/2026
3/31/2025
3/31/2024
3/31/2023
Total Revenue
103,302
99,332
108,332
113,054
108,096
Cost of Revenue
46,764
44,922
51,748
53,540
48,058
Gross Profit
56,538
54,410
56,584
59,514
60,038
Operating Expense
49,439
48,575
44,663
46,727
51,549
Operating Income
7,099
5,835
11,921
12,787
8,489
Net Non Operating Interest Income Expense
-5,049
-5,201
-8,195
-13,364
-13,606
Other Income Expense
-4,438
-2,908
-2,286
683
76
Pretax Income
-2,388
-2,274
1,440
106
-5,041
Tax Provision
-22
120
-807
320
-6,262
Net Income Common Stockholders
-2,366
-2,394
2,247
-214
1,221
Diluted NI Available to Com Stockholders
-2,366
-2,394
2,247
-214
1,221
Basic EPS
-0.07
-0.07
0.09
-0.01
0.06
Diluted EPS
-0.07
-0.07
0.08
-0.01
0.06
Basic Average Shares
32,209.83
32,316.78
25,821.87
22,321.45
19,976.17
Diluted Average Shares
32,209.83
32,316.78
26,508.91
22,321.45
20,523.80
Total Operating Income as Reported
6,400
5,136
8,223
10,794
7,614
Total Expenses
96,203
93,497
96,411
100,267
99,607
Net Income from Continuing & Discontinued Operation
-2,366
-2,394
2,247
-214
1,221
Normalized Income
2,031.11
-649.20
3,939.10
-719.56
1,164.78
Interest Expense
5,049
5,201
8,195
13,364
13,606
Net Interest Income
-5,049
-5,201
-8,195
-13,364
-13,606
EBIT
2,661
2,927
9,635
13,470
8,565
EBITDA
12,382
12,661
16,813
19,276
14,646
Reconciled Cost of Revenue
37,330
35,475
44,823
47,985
42,330
Reconciled Depreciation
9,721
9,734
7,178
5,806
6,081
Net Income from Continuing Operation Net Minority Interest
-2,366
-2,394
2,247
-214
1,221
Total Unusual Items Excluding Goodwill
-4,438
-2,908
-2,286
683
76
Total Unusual Items
-4,438
-2,908
-2,286
683
76
Normalized EBITDA
16,820
15,569
19,099
18,593
14,570
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-40.89
-1,163.20
-593.90
177.44
19.78
3/31/2023 - 1/9/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: